STAT

MAY 24, 2025

Florida has just banned fluoride in public water , becoming the second state to do so. It’s part of decadeslong battle that has heated up in recent years. Local governments debate whether it belongs in the water supply. Parents question safety. Pseudoscience clouds public perception. Often, the conversation is framed as a domestic ideological battle between personal liberty and public health mandates.

363

363

PharmaVoice

MAY 15, 2025

Amy Parison, who stepped into the lead financial role at the company in March, is managing Editas Medicine’s transition to a new gene editing platform while recovering from a major overhaul.

173

173

BioPharma Dive

MAY 15, 2025

A gene editing drug custom-made for a critically ill baby showed that, for some ultra-rare diseases, it’s possible to design and test a new CRISPR medicine in just a few months.

127

127

Pharma Times

MAY 15, 2025

Aspire-FTD study aims to stop disease progression with one-time treatment

131

131

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Express Pharma

MAY 29, 2025

Indias pharmaceutical industry is one of the largest in the world, playing a crucial role in both domestic healthcare and global drug supply. But behind the innovation and scale lies a web of regulations that pharma companies must follow closely. Compliance in this sector is non-negotiable; it impacts everything from manufacturing and labour to environmental practices and global trade.

Documentation 104

Documentation Pharmaceutical Companies Pharmaceutical Companies 104

STAT

MAY 20, 2025

A new framework for Covid-19 vaccines announced by Food and Drug Administration leaders Tuesday suggests the agency will no longer approve new Covid vaccines for healthy individuals under 65, including babies, without data from new randomized clinical trials showing their benefit.  The plan — described in a commentary in the New England Journal of Medicine, followed by a live stream on YouTube — created confusion among physicians about what it means for young children.

Vaccines 363

Vaccines 363

PharmaVoice

MAY 16, 2025

A stealth startup built by the partner of disgraced Theranos founder Elizabeth Holmes is taking a shot at a new blood test — an area where other companies are already making strides.

235

235

BioPharma Dive

MAY 29, 2025

A therapy at the center of their $22 billion alliance failed to extend survival in a type of lung tumor, leading the companies to abandon a U.S. submission.

112

112

Pharmaceutical Technology

MAY 29, 2025

The HSS has terminated a contract previously awarded to Moderna to help advance a vaccine candidate targeting bird flu.

Vaccines 111

Vaccines 111

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Express Pharma

MAY 28, 2025

Global pharma supply chains are undergoing a fundamental shift in the backdrop of key US legislation that is set to pass soon. Since the late 90s, as drug discovery started to expand significantly in the US, the development model has evolved to increasingly rely on outsourcing. This evolution saw the development of China as a key partner they capitalised well on the opportunity and developed a strong CDMO industry catering to US biopharma.

Pharmaceutical Manufacturing 97

Pharmaceutical Manufacturing Drug Development 97

FDA Law Blog: Biosimilars

MAY 27, 2025

By Dr. Naomi Lowy, Principal Drug Regulatory Expert FDA recently announced, CEO Forums: An FDA Listening Tour to Engage Pharma CEOs. These are scheduled to take place in several cities on both coasts in June and July (Link here). This tour to engage with pharmaceutical and biotech CEOs is unprecedented. According to the announcement, Commissioner Makary will be holding these along with Principal Deputy Commissioner Sara Brenner, M.D., M.P.H and Director of FDAs Center for Biologics Evaluation a

110

110

STAT

MAY 28, 2025

Robert F. Kennedy Jr.’s unilateral decision that the Centers for Disease Control and Prevention would no longer recommend Covid-19 boosters for healthy people during childhood or pregnancy represents a bulldozing of safeguards intended to keep public health officials honest and their decisions transparent. It also tramples on individuals’ ability to make their own decisions about medical evidence.

Vaccines 363

Vaccines 363

PharmaVoice

MAY 2, 2025

Regulators have signaled their willingness to embrace alternative tests and guide the industry in new directions.

194

194

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

BioPharma Dive

MAY 20, 2025

The agency will now require randomized, controlled data before approving new COVID shots for healthy children and adults, Commissioner Martin Makary and top vaccine official Vinay Prasad wrote in NEJM.

Vaccines 101

Vaccines 101

European Pharmaceutical Review

MAY 29, 2025

Research has illustrated a potential new device for harvesting T cells that could improve the cost-effectiveness of manufacturing CAR T-cell therapy and make the cancer immunotherapy more accessible to patients. In development by investigators in the US, the device, called capture and glow (CAPGLO), captures T cells via a magnetic field and makes them visible using glowing fluorescent tags.

98

98

Express Pharma

MAY 11, 2025

Accretion Pharmaceuticals, an Ahmedabad-headquartered pharmaceuticals manufacturer, announced that its initial public offering (IPO) will open for subscription on Wednesday, May 14, 2025. The anchor portion will be opened on Tuesday, May 13, 2025, and the issue will conclude on Friday, May 16, 2025. The company intends to raise 29.75 crore from the offering and aims to be listed on the NSE Emerge platform.

Pharmaceutical Manufacturing 101

Pharmaceutical Manufacturing Diabetes 101

pharmaphorum

MAY 22, 2025

The FDA has instructed Pfizer and Moderna to add stronger warnings to the labels of their COVID-19 vaccines about the risk of cardiotoxicity

Vaccines 136

Vaccines Labelling 136

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MAY 15, 2025

I always knew Elizabeth Holmes would have a second act. But I’m shocked it’s starting while she’s still behind bars. Elizabeth is now serving an 11-year sentence for defrauding investors in Theranos and has been banned from participating in federal health programs. The company was built on her claim that, at 19 years old, she had invented a device capable of running hundreds of tests from just a single drop of blood.

357

357

PharmaVoice

MAY 19, 2025

HHS issued guidance for the third cycle, teeing up another 15 drugs to be selected by early next year.

182

182

BioPharma Dive

MAY 15, 2025

Shares of the biotech fell around 15% on news the FDA is not only taking longer to review the drug, but will assemble an outside group of advisers to evaluate it as well.

99

99

Pharmaceutical Technology

MAY 15, 2025

The FDA has approved MSDs Welireg for rare adrenal tumours, and AbbVies Emrelis for treating c-Met+ lung cancer patients.

110

110

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

The Pharmacist

MAY 30, 2025

PCN pharmacy lead Gareth Malson offers his top ten tips for supporting people with diabetes to improve control of their condition at regular review The prevalence of diabetes is continuing to rise at an alarming rate. In 2023-24, the national diabetes register increased by around 21 people every hour, with 4.6m living with diabetes in […] The post Ten tips for providing effective diabetes reviews appeared first on The Pharmacist.

Diabetes 93

Diabetes 93

The Guardian - Pharmaceutical Industry

MAY 21, 2025

Brand shifts away from dieting towards weight-loss injections after filing for bankruptcy in the US WeightWatchers is teaming up with a provider of weight-loss drugs such as Wegovy and Mounjaro, in a seismic shift for the brand away from a focus on dieting as it tries to turn around its struggling business. WeightWatchers, which has promoted a non-medical, points-based approach to food intake since its creation in the 1960s , has announced a strategic partnership in the UK with CheqUp, a provide

87

87

STAT

MAY 1, 2025

The era of “tranq” may be ending. But tranq, as the powerful veterinary tranquilizer xylazine is known in the illicit drug supply, is being replaced at least in part by a dangerous new sedative: medetomidine. In the past year, the anesthetic has become an increasingly common element in the drug supply, with cities and states including Philadelphia, Pittsburgh, Chicago, and San Francisco reporting cases of medetomidine-involved overdoses.

320

320

PharmaVoice

MAY 7, 2025

RFK Jr.’s plan to ban TV advertising may shift more marketing attention to online platforms.

182

182

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

BioPharma Dive

MAY 6, 2025

A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic medicines, adding more uncertainty to an already struggling field of research.

84

84

Drug Patent Watch

MAY 28, 2025

"Generic Medications: The Unseen Struggle for Quality Control As the pharmaceutical industry grapples with the complexities of generic drug production, a hidden crisis is unfolding. Despite their lower price points, generic medications often fall short of their branded counterparts in terms of quality and consistency. But what if I told you there's a way to bridge this gap?

88

88

The Pharmacist

MAY 28, 2025

Wandle PCN collaborated with the Central London Community Healthcare NHS Trust (CLCH) to launch a pharmacist-led initiative to tackle hypertension. The collaboration saw a group of pharmacists organise a hypertension event, targeting high-risk individuals who did not engage with primary care for health checks. CLCH senior clinical pharmacist Upriya Patel explains more.

80

80